ClinVar Miner

Variants studied for cerebral palsy

Included ClinVar conditions (17):
Minimum submission review status: Collection method:
Minimum conflict level:
Gene type:
ClinVar version:

If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.

pathogenic likely pathogenic uncertain significance likely benign benign risk factor other total
36 33 171 120 20 7 1 373

Gene and significance breakdown #

Total genes and gene combinations: 61
Download table as spreadsheet
Gene or gene combination pathogenic likely pathogenic uncertain significance likely benign benign risk factor other total
GAD1 1 2 83 85 15 0 0 174
KANK1 0 0 62 33 3 0 0 98
HPDL 12 4 3 1 0 0 0 19
GAD1, LOC132088794 0 0 5 1 2 0 0 8
ADD3 3 1 2 0 0 0 0 4
COL4A2 0 4 0 0 0 0 0 4
KANK1, LOC126860554 0 0 4 0 0 0 0 4
SPAST 1 1 0 0 0 0 1 3
​intergenic 0 1 1 0 0 0 0 2
COL4A1 1 1 0 0 0 0 0 2
F2 0 0 0 0 0 2 0 2
GAD1, LOC129935083 0 0 2 0 0 0 0 2
PMM2 2 0 0 0 0 0 0 2
TUBA1A 1 0 1 0 0 0 0 2
TUBB4A 1 1 0 0 0 0 0 2
ADAP2, ATAD5, COPRS, CRLF3, EVI2A, EVI2B, LRRC37B, MIR193A, NF1, OMG, RAB11FIP4, RNF135, SUZ12, TEFM, UTP6 1 0 0 0 0 0 0 1
AIFM3, ARVCF, C22orf39, CDC45, CLDN5, CLTCL1, COMT, CRKL, DGCR2, DGCR6, DGCR6L, DGCR8, ESS2, FAM230A, GGTLC3, GNB1L, GP1BB, GSC2, HIRA, KLHL22, LZTR1, MED15, MRPL40, P2RX6, PI4KA, PRODH, RANBP1, RIMBP3, RTL10, RTN4R, SCARF2, SEPTIN5, SERPIND1, SLC25A1, SLC7A4, SNAP29, TANGO2, TBX1, THAP7, TMEM191B, TRMT2A, TSSK2, TXNRD2, UFD1, USP41, ZDHHC8, ZNF74 1 0 0 0 0 0 0 1
ALDH3A2 1 0 0 0 0 0 0 1
ANKRD34A, ANKRD35, HJV, ITGA10, LIX1L, NUDT17, PEX11B, PIAS3, POLR3C, POLR3GL, RBM8A, RNF115, TXNIP 0 0 0 0 0 1 0 1
ARFGEF1-DT, CPA6 0 1 0 0 0 0 0 1
ARHGAP31 0 1 0 0 0 0 0 1
ASTN2, TRIM32 0 0 0 0 0 1 0 1
ATP10A, CYFIP1, GOLGA6L1, GOLGA6L2, IPW, MAGEL2, MKRN3, NDN, NIPA1, NIPA2, NPAP1, PWAR1, PWAR4, PWAR5, PWAR6, PWARSN, PWRN1, PWRN2, SNORD115-1, SNORD116-1, SNRPN, SNURF, TUBGCP5, UBE3A 0 0 0 0 0 1 0 1
BRCA2 0 1 0 0 0 0 0 1
BUB1B 0 0 1 0 0 0 0 1
CACNA1A 0 1 0 0 0 0 0 1
CACNA1C 0 1 0 0 0 0 0 1
CC2D1A, LOC129391070 0 1 0 0 0 0 0 1
CLCN1 1 0 0 0 0 0 0 1
CLCN2 0 1 0 0 0 0 0 1
EGFR 0 0 1 0 0 0 0 1
F8 0 0 0 0 0 1 0 1
FBXO31 0 1 0 0 0 0 0 1
GALC 0 0 1 0 0 0 0 1
GNB1 1 0 0 0 0 0 0 1
GPHN, PALS1 1 0 0 0 0 0 0 1
GRIN2B 0 1 0 0 0 0 0 1
HPDL, LOC129930439 1 0 0 0 0 0 0 1
HPDL, LOC129930440 1 0 0 0 0 0 0 1
HTT 0 0 1 0 0 0 0 1
IDH3G 0 0 1 0 0 0 0 1
ISCA2 0 1 0 0 0 0 0 1
KANK1, LOC124210605, LOC126860553, LOC126860554, LOC129390062 1 0 0 0 0 0 0 1
KIDINS220 0 1 0 0 0 0 0 1
KLHL3 0 1 0 0 0 0 0 1
MFN2 0 1 0 0 0 0 0 1
MT-TL1 1 0 0 0 0 0 0 1
NECTIN2 0 0 1 0 0 0 0 1
NKX2-6 0 0 0 0 0 1 0 1
PDGFRB 0 1 0 0 0 0 0 1
PIEZO2 0 0 1 0 0 0 0 1
PNPLA4, PUDP, STS, VCX, VCX2, VCX3A 1 0 0 0 0 0 0 1
PROC 0 1 0 0 0 0 0 1
RNASEH2B 1 0 0 0 0 0 0 1
SAMHD1 1 0 0 0 0 0 0 1
SETX 0 1 0 0 0 0 0 1
SMARCA4 1 0 0 0 0 0 0 1
SYNE2 1 0 0 0 0 0 0 1
TARS2 0 0 1 0 0 0 0 1
TTN 0 1 0 0 0 0 0 1
ZDHHC15 0 1 0 0 0 0 0 1

Submitter and significance breakdown #

Total submitters: 34
Download table as spreadsheet
Submitter pathogenic likely pathogenic uncertain significance likely benign benign risk factor other total
Invitae 1 1 45 82 8 0 0 137
Fulgent Genetics, Fulgent Genetics 0 0 53 33 2 0 0 88
Illumina Laboratory Services, Illumina 0 0 46 4 13 0 0 63
Neurogenetics Research Program, University of Adelaide 11 18 6 0 0 7 1 43
OMIM 16 0 1 0 0 0 0 17
Baylor Genetics 1 1 8 0 0 0 0 10
NIHR Bioresource Rare Diseases, University of Cambridge 2 2 0 0 0 0 0 4
Revvity Omics, Revvity 0 0 3 0 0 0 0 3
Institute of Human Genetics, University of Leipzig Medical Center 1 0 2 0 0 0 0 3
Yale Center for Mendelian Genomics, Yale University 0 2 1 0 0 0 0 3
Centre of Medical Genetics, University of Antwerp 2 0 0 0 0 0 0 2
Talkowski Laboratory, Center for Human Genetic Research, Massachusetts General Hospital 0 1 1 0 0 0 0 2
Centre for Mendelian Genomics, University Medical Centre Ljubljana 0 0 1 0 1 0 0 2
Equipe Genetique des Anomalies du Developpement, Université de Bourgogne 0 2 0 0 0 0 0 2
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City 0 1 1 0 0 0 0 2
Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet 0 0 1 0 0 0 0 1
Centogene AG - the Rare Disease Company 1 0 0 0 0 0 0 1
ClinVar Staff, National Center for Biotechnology Information (NCBI) 1 0 0 0 0 0 0 1
Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital & Research Centre 0 1 0 0 0 0 0 1
Genomic Research Center, Shahid Beheshti University of Medical Sciences 0 0 0 1 0 0 0 1
Division of Human Genetics, Children's Hospital of Philadelphia 0 0 1 0 0 0 0 1
Kruer lab, Phoenix Children's Hospital 0 1 0 0 0 0 0 1
Gene Discovery Core-Manton Center, Boston Children's Hospital 1 0 0 0 0 0 0 1
Medical Genetics and Mitochondrial Research group, Latvian Biomedical Research and Study center 1 0 0 0 0 0 0 1
Center for Molecular Medicine, Children’s Hospital of Fudan University 1 0 0 0 0 0 0 1
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego 0 1 0 0 0 0 0 1
Department of Pathology and Laboratory Medicine, Sinai Health System 0 0 1 0 0 0 0 1
TIDEX, University of British Columbia 0 0 1 0 0 0 0 1
Genomic Medicine Lab, University of California San Francisco 0 1 0 0 0 0 0 1
Diagnostics Services (NGS), CSIR - Centre For Cellular And Molecular Biology 0 0 1 0 0 0 0 1
Genome-Nilou Lab 0 0 0 1 0 0 0 1
Neuberg Supratech Reference Laboratories Pvt Ltd, Neuberg Centre for Genomic Medicine 0 0 1 0 0 0 0 1
Centre de recherche CHU de Quebec-Universite Laval, Laval University 0 1 0 0 0 0 0 1
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein 0 0 1 0 0 0 0 1

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.